PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
19-Feb-2026 Animate Biosciences Reports Preclinical Data Showing Dramatic Reduction in Cardiac Scarring and Near-Doubling of Heart Function After Experimental Heart Attack Businesswire
19-Feb-2026 Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis Businesswire
19-Feb-2026 New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer Businesswire
19-Feb-2026 ImmunityBio Expands Access to ANKTIVA® in EU with New Distribution Partnership and Opens Irish Subsidiary to Support European Launch Businesswire
19-Feb-2026 Aeris Integrates with Palo Alto Networks to Secure the Wireless IoT Blind Spot with Agentless, Global SASE Businesswire
19-Feb-2026 GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency Businesswire
19-Feb-2026 Integrated Biosciences Appoints Tony Wu, Co-Founder of xAI, to its Scientific Advisory Board Businesswire
19-Feb-2026 PharmaMar looks to accelerate oncology research with AI through collaboration with Globant PharmaMar
19-Feb-2026 Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference Businesswire
19-Feb-2026 OmniAb to Report Fourth Quarter 2025 Financial Results on March 4 Businesswire
19-Feb-2026 Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data Businesswire
19-Feb-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
19-Feb-2026 Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery Businesswire
19-Feb-2026 Novartis Pluvicto (lutetium (177Lu) vipivotide tetraxetan)▼ receives MHRA authorisation for new indication for eligible patients with PSMA‑positive metastatic castration‑resistant prostate cancer Novartis
19-Feb-2026 RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer J & J
19-Feb-2026 WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research Businesswire
19-Feb-2026 Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026 Businesswire
19-Feb-2026 YolTech Therapeutics Announces Positive Interim Data on YOLT-202 for the Treatment of Alpha-1 Antitrypsin Deficiency Businesswire
19-Feb-2026 VivaMed BioPharma Partners With Syngene International to Advance AI-Derived Repurposed Therapeutic Programs Through Global Validation Infrastructure Businesswire
19-Feb-2026 Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease Over Two RSV Seasons Businesswire